Combination of Biologic and Anti-obesity Therapies in Psoriatic Arthritis

NCT07443956 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Psoriatic Arthritis (PsA)
Obesity & Overweight

Interventions

DRUG: Ixekizumab
DRUG: Tirzepatide

Sponsor

NHS Greater Glasgow and Clyde

Collaborators

[object Object]
[object Object]